https://orcid.org/0000-0001-7237-9847
References
- Song SJ, Han K, Choi KS et al. Trends in diabetic retinopathy and related medical practices among type 2 diabetes: results from the national insurance service survey 2006‐2013. J Diabetes Investig 2018; 9: 173–178.
- Behl T, Velpandian T, Kotwani A. Role of altered coagulation‐fibrinolytic system in the pathophysiology of diabetic retinopathy. Vascul Pharmacol 2017; 92: 1–5.
- Wu L, Fernandez‐loaiza P, Sauma J et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 2013; 4: 290–294.
- Iwase T, Kobayashi M, Yamamoto K et al. Effects of photocoagulation on ocular blood flow in patients with severe non‐proliferative diabetic retinopathy. PLoS One 2017; 12: e0174427.
- Chew EY, Ferris FL 3rd, Csaky KG et al. The long‐term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow‐up study. Ophthalmology 2003; 110: 1683–1689.
- Muqit MM, Young LB, Mckenzie R et al. Pilot randomised clinical trial of Pascal TargETEd retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol 2013; 97: 220–227.
- Mistry H, Auguste P, Lois N et al. Diabetic retinopathy and the use of laser photocoagulation: is it cost‐effective to treat early? BMJ Open Ophthalmol 2017; 2: e000021.
- Ito A, Hirano Y, Nozaki M et al. Short pulse laser induces less inflammatory cytokines in the murine retina after laser photocoagulation. Ophthalmic Res 2015; 53: 65–73.
- Takamura Y, Arimura S, Miyake S et al. Panretinal photocoagulation using short‐pulse laser induces less inflammation and macular thickening in patients with diabetic retinopathy. J Ophthalmol 2017; 2017: 8530261.
- Bone RA, Landrum JT. Comments on enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: CREST‐report 1. Invest Ophthalmol Vis Sci 2016; 57: 5415.
- Bone RA, Landrum JT, Mukherjee A. Efficacy of Diacetate esters of macular carotenoids: effect of supplementation on macular pigment. J Nutr Metab 2018; 2018: 4632081.
- Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med 2005; 26: 459–516.
- She CY, Gu H, Xu J et al. Association of macular pigment optical density with early stage of non‐proliferative diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol 2016; 9: 1433–1438.
- Nolan JM, Power R, Stringham J et al. Enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: central retinal enrichment supplementation trials ‐ report 1. Invest Ophthalmol Vis Sci 2016; 57: 3429–3439.
- Cennamo G, Lanni V, Abbate R et al. The relationship between macular pigment and vessel density in patients with type 1 diabetes mellitus. Ophthalmic Res 2018; 11: 1–7.
- Putnam CM. Clinical imaging of macular pigment optical density and spatial distribution. Clin Exp Optom 2017; 100: 333–340.
- Howells O, Eperjesi F, Bartlett H. Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 2011; 249: 315–347.
- Crochet M, Zanlonghi X, Charlier J. Density with a color perimetry technique. Normal values and influence of diet. ARVO annual meeting. Invest Ophthalmol Vis Sci 2009; 50: 2743.